Skip to main content
Premium Trial:

Request an Annual Quote

Exact Sciences Signs Cologuard Coverage Contract with Anthem Blue Cross Blue Shield

NEW YORK (GenomeWeb) – Exact Sciences said today that it has signed an in-network coverage contract for the Cologuard colon cancer screening test with Anthem Blue Cross Blue Shield.

Patients covered by the insurance company in Indiana, Ohio, Kentucky, Missouri, and Wisconsin will now have access to the test as an in-network service.

"As Cologuard's in-network status grows in 2016, more people gain access to this innovative screening test. This access gives us more opportunities to find cancer in its earliest, most treatable stages," said Exact Chairman and CEO Kevin Conroy in a statement. "The momentum continues to build for Cologuard's commercial coverage and contracting. Along with more patients gaining in-network access to our test, the execution of our sales strategy and our consumer marketing efforts continue to drive Cologuard awareness among both patients and physicians."

In February, Exact announced it had signed a similar in-network coverage contract for Cologuard with Anthem Blue Cross Blue Shield in Georgia and Virginia. The test is also covered by Blue Cross Blue Shield in North Carolina, however Exact has filed a lawsuit in the United States District Court for the Middle District of North Carolina for "improperly and illegally adopt[ing] an official policy of denying benefits and refusing to pay Exact" for the costs of performing Cologuard.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.